Literature DB >> 24460120

Cryptogenic stroke and diabetes: a probable link between silent atrial fibrillation episodes and cerebrovascular disease.

Raffaele Marfella1, Maria R Rizzo, Maria C Capoluongo, Maria Ambrosino, Antonella Savinelli, Francesca Cinone, Giuseppe Martinelli, Ilaria Fava, Antonello Petrella, Michelangela Barbieri, Giuseppe Paolisso.   

Abstract

Diabetes mellitus is a risk factor for cardiovascular and cerebrovascular events independently of other factors such as age, sex, BMI and blood pressure. Diabetes plays an important role in the pathogenesis of atrial fibrillation because it causes alterations to the autonomic nervous system. It may also be associated with an increased prevalence of asymptomatic episodes of atrial fibrillation, which cause cerebrovascular disease more often than chronic atrial fibrillation. The presence of silent cerebral ischemia doubles the risk of stroke in the general population independently of other cardiovascular risk factors; therefore, early detection of these episodes is important to determine preventive measures against the first cerebrovascular disease.

Entities:  

Mesh:

Year:  2014        PMID: 24460120     DOI: 10.1586/14779072.2014.882230

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

Review 1.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

2.  Study on the incidence and risk factor of silent cerebrovascular disease in young adults with first-ever stroke.

Authors:  Huimin Fan; Xuezeng Hao; Shuna Yang; Yue Li; Wei Qin; Lei Yang; Junliang Yuan; Wenli Hu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  Cerebrovascular risk factors associated with ischemic stroke in a young non-diabetic and non-hypertensive population: a retrospective case-control study.

Authors:  Nan Zhang; Lin Zhang; Qiu Wang; Jingwei Zhao; Jia Liu; Guang Wang
Journal:  BMC Neurol       Date:  2020-11-23       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.